Login / Signup

Exploring the antihyperglycemic potential of tetrapeptides devised from AdMc1 via different receptor proteins inhibition using in silico approaches.

Ghulam MustafaHafiza S MahroshMuddassar ZafarSyed A AttiqueRawaba Arif
Published in: International journal of immunopathology and pharmacology (2022)
In the light of overall results of all analyses employed in this study, the selected ligands could be further processed as potential hypoglycaemic drug candidates.
Keyphrases
  • human health
  • risk assessment
  • adverse drug
  • climate change
  • drug induced